Gladstone Capital (GLAD) Tops Q4 Earnings and Revenue Estimates — Positive
GLAD Zacks Investment Research — November 17, 2025Gladstone Capital (GLAD) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.5 per share a year ago.
Warren Buffett's Berkshire Hathaways Just Bought Google Stock. Should You? — Positive
BRK-A BRK-B GOOG GOOGL Investopedia — November 17, 2025Warren Buffett's Berkshire Hathaway is making a big bet on one of the hottest tech stocks.
Since its 2024 merger, Trump Media has reported low quarterly revenues with no growth. Operating expenses, meanwhile, have been larger and have increased.
Whirlpool's Worst May Be Over—Upside Opportunity Ahead — Positive
WHR MarketBeat — November 17, 2025Whirlpool's NYSE: WHR stock downtrend may not be over; however, the technical, fundamental, and market forces are aligning, suggesting downside is severely limited and the upside potential is robust.
Helmerich & Payne (HP) Reports Q4 Loss, Beats Revenue Estimates — Neutral
HP Zacks Investment Research — November 17, 2025Helmerich & Payne (HP) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.26. This compares to earnings of $0.76 per share a year ago.
MRX Deadline: MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit — Neutral
MRX PRNewsWire — November 17, 2025NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Under the Patronage of the Minister of Municipal and Rural Affairs and Housing: Agreement to Establish an Advanced Mortgage Finance Platform — Neutral
BAM PRNewsWire — November 17, 2025A partnership including: REDF, SRC LCM Partners LONDON , Nov. 17, 2025 /PRNewswire/ -- Under the patronage and presence of His Excellency Mr. Majed bin Abdullah Al-Hogail, Minister of Municipal and Rural Affairs and Housing and Chairman of the Board of the Real Estate Development Fund, the Real Estate Development Fund (REDF) and the Saudi Real Estate Refinance Company (SRC), announced the signing of a tripartite partnership with LCM Partners.
Is Nvidia Stock a Buy, Sell or Hold Ahead of Earnings? — Positive
NVDA 24/7 Wall Street — November 17, 2025It's been a very strong quarter for big tech earnings, but that meant much for the share prices of the season's earnings beaters.
Market Broadening a Key Question for Advisors in 2026 — Neutral
ELFY SMTH ETF Trends — November 17, 2025The central question facing investors heading into 2026 is whether market performance will finally extend beyond the handful of megacap technology companies that have dominated returns for the past three years.
XPeng delivered a standout Q3'25, with sales up over 100% and EV deliveries surging 149% year-over-year. XPEV's affordable Mona EV lineup drove record volumes, while the company pushes into robotaxi and humanoid robot markets, boosting its tech profile. Despite strong sales and improving margins, XPEV remains unprofitable, but forecasts a small Q4 profit and holds a solid cash position.
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript — Neutral
ANIX Seeking Alpha — November 17, 2025Anixa Biosciences, Inc. ( ANIX ) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs November 11, 2025 2:00 PM EST Company Participants Amit Kumar - CEO, Chairman & Co-Chair of CBAB Conference Call Participants Robert Sassoon - Water Tower Research LLC Presentation Robert Sassoon Water Tower Research LLC Hello, everybody. I'm Robert Sassoon.
BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript — Neutral
BNTX Seeking Alpha — November 17, 2025BioNTech SE ( BNTX ) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies November 11, 2025 9:00 AM EST Company Participants Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Özlem Türeci - Co-Founder, Chief Medical Officer & Member of Management Board Ilhan Celik Michael Wenger Ramón Zapata-Gomez - CFO & Member of Management Board Douglas Maffei - Vice President of Strategy & Investor Relations Annemarie Hanekamp - Chief Commercial Officer & Member of Management Board Conference Call Participants Daina Graybosch - Leerink Partners LLC, Research Division Tazeen Ahmad - BofA Securities, Research Division Jay Lee …
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates — Negative
LFMD Zacks Investment Research — November 17, 2025LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.14 per share a year ago.
BP was responding to a release of refined products on the Olympic Pipeline System east of Everett, Washington, and had partially restored part of the system, the company said on Monday.
Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031 — Neutral
MOH Business Wire — November 17, 2025LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the “Notes”) to be sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in reliance on Regulation S under.
Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy — Neutral
JNJ Business Wire — November 17, 2025LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics announced its acquisition by Johnson & Johnson (NYSE: JNJ) for $3.05 billion, marking a historic moment for the Vida III portfolio. Hald.
Stifel's Stephen Gengaro shares his bull case for Tesla — Positive
SF TSLA CNBC Television — November 17, 2025Stephen Gengaro, Stifel, joins 'Fast Money' to talk his bullish take on Tesla.
Archer Aviation to supply electric powertrain to Anduril, EDGE for Omen drone — Positive
ACHR Reuters — November 17, 2025Archer Aviation said on Monday it will supply its electric powertrain for the Omen autonomous air vehicle, being co-developed by U.S. defense technology firm Anduril Industries and UAE-based EDGE group.
Explaining the K-Shaped Economy: Inflation, FOMC & TGT Barometers — Neutral
TGT Schwab Network — November 17, 2025Jim Bianco (@BiancoResearch) says inflation is a bigger problem for the economy instead of jobs. He explains how the "K-shaped economy" many experts have hinted toward is closely tied to rising inflation, using Target (TGT) as a barometer for his metrics.
Archer to Supply Its Proprietary Electric Powertrain to Third Parties, Starting with Anduril and EDGE Group for their Recently Announced Omen Autonomous Air Vehicle — Neutral
ACHR Business Wire — November 17, 2025DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $ACHR--Archer Aviation Inc. (NYSE: ACHR) today announced an agreement to supply Anduril Industries and EDGE Group with Archer's dual use electric powertrain technology to accelerate the development and scaled production of Anduril's recently unveiled Omen Autonomous Air Vehicle system. The UAE has committed to an initial acquisition of 50 Omen systems, creating an established demand signal for the Omen system and Archer's powertrain technology. The agreeme.